Thomas Quertermous
NIH Rank #1002
- R01 Holder
- Top 10% Funded
- Early Career
- Mentor
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1881867Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Surgery
- Internal Medicine
NIH Funding · FY2024
Linked Award Amount
$5.3M
Full award amounts, FY2024
Award Records
7
Records listing this PI
Award-Linked Rank
#1,002
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Thomas Quertermous as a PI. Multi-PI records show the full award amount for context.
- 5UM1HG011972-04UM1Stanford Center for Connecting DNA Variants to Function and Phenotype$1.8Maward amount
- 1R01HL171045-01A1R01Gene regulatory networks controlling smooth muscle phenotype and vasculardisease risk$694.6Kaward amount
- 5R01HL156846-04R01PDGFD regulates a transcriptional network to modulate smooth muscle cell transition and coronary artery disease risk$661.6Kaward amount
- 5R01HL151535-04R01Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway.$654.3Kaward amount
- 5R01HL158525-03R01Molecular mechanisms of vascular calcification and their connection to coronary disease risk$579.2Kaward amount
- 5R01HL134817-08R01Causal variant association mechanisms in TCF21 binding coronary disease loci$553.4Kaward amount
- $329.6Kaward amount
Award organization
Organizations that administered FY2024 awards listing Thomas Quertermous as a PI.
FY2024 award administered by Stanford University (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardStanford University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1002
- 2024Entered Top 25% NationallyRanked #1002
- 2024Entered Top 10% NationallyRanked #1002
- 2025$10M Cumulative Funding
- 2025R01 Grant Holder
- 2026Entered Top 5% NationallyRanked #769
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Thomas Quertermous.